Are we making progress in diagnosing and preventing gastrointestinal cancers?

Abstract

References

Abe, N. , Sugiyama, M. , Masaki, T. , Ueki, H. , Yanagida, O. , Mori, T. et al. (2004) Predictive factors for lymph node metastasis of differentiated submucosally invasive gastric cancer. Gastrointest Endosc 60: 242-245.

Adler, A. , Aschenbeck, J. , Yenerim, T. , Mayr, M. , Aminalai, A. , Drossel, R. et al. (2009) Narrow-band versus white-light high definition television endoscopic imaging for screening colonoscopy: a prospective randomized trial . Gastroenterology 136: 410-416.

Ancona, E. , Rampado, S. , Cassaro, M. , Battaglia, G. , Ruol, A. , Castoro, C. et al. (2008) Prediction of lymph node status in superficial esophageal carcinoma. Ann Surg Oncol 15: 3278-3288.

Bateman, D.N. , Colin-Jones, D. , Hartz, S. , Langman, M. , Logan, R.F. , Mant, J. et al. (2003) Mortality study of 18 000 patients treated with omeprazole. Gut 52: 942-946.

Bertagnolli, M.M. , Eagle, C.J. , Zauber, A.G. , Redston, M. , Solomon, S.D. , Kim, K. et al. (2006) Celecoxib for the prevention of sporadic colorectal adenomas. N Engl J Med 355: 873-884.

Bollschweiler, E. , Baldus, S.E. , Schroder, W. , Prenzel, K. , Gutschow, C. , Schneider, P.M. et al. (2006) High rate of lymph-node metastasis in submucosal esophageal squamous-cell carcinomas and adenocarcinomas. Endoscopy 38: 149-156.

Bouvier, A.M. , Binquet, C. , Gagnaire, A. , Jouve, J.L. , Faivre, J. and Bedenne, L. ( 2006) Management and prognosis of esophageal cancers: has progress been made? Eur J Cancer 42: 228-233.

Cao, Y. , Liao, C. , Tan, A. , Gao, Y. , Mo, Z. and Gao, F. (2009) Meta-analysis of endoscopic submucosal dissection versus endoscopic mucosal resection for tumors of the gastrointestinal tract. Endoscopy 41: 751-757.

Chung, I.K. , Lee, J.H. , Lee, S.H. , Kim, S.J. , Cho, J.Y. , Cho, W.Y. et al. (2009) Therapeutic outcomes in 1000 cases of endoscopic submucosal dissection for early gastric neoplasms: Korean ESD Study Group multi-center study. Gastrointest Endosc 69: 1228-1235.

10.

Craanen, M.E. and Kuipers, E.J. ( 2001) Advantages and disadvantages of population screening for cancer and surveillance of at-risk groups. Best Pract Res Clin Gastroenterol 15: 211-226.

11.

de Vries, A.C. , Haringsma, J. , de Vries, R.A. , ter Borg, F. , Nagtzaam, N.M. , Steyerberg, E.W. et al. (2009a) The use of clinical, histologic, and serologic parameters to predict the intragastric extent of intestinal metaplasia: a recommendation for routine practice. Gastrointest Endosc 70: 18-25.

12.

de Vries, A.C. , Kuipers, E.J. and Rauws, E.A. (2009b) Helicobacter pylori eradication and gastric cancer: when is the horse out of the barn? Am J Gastroenterol 104: 1342-1345.

13.

de Vries, A.C. , van Grieken, N.C. , Looman, C.W. , Casparie, M.K. , de Vries, E. , Meijer, G.A. et al. (2008) Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands. Gastroenterology 134: 945-952.

14.

Deyhle, P. , Seuberth, K. , Jenny, S. and Demling, L. ( 1971) Endoscopy polypectomy in the proximal colon. Endoscopy 3: 103-115.

15.

El-Serag, H.B. , Aguirre, T.V. , Davis, S. , Kuebeler, M. , Bhattacharyya, A. and Sampliner, R.E. ( 2004) Proton pump inhibitors are associated with reduced incidence of dysplasia in Barrett’s esophagus. Am J Gastroenterol 99: 1877-1883.

16.

Endo, M. and Kawano, T. ( 1997) Detection and classification of early squamous cell esophageal cancer. Dis Esophagus 10: 155-158.

17.

Everett, S.M. and Axon, A.T. ( 1998) Early gastric cancer: disease or pseudo-disease? Lancet 351: 1350-1352.

18.

Fearon, E.R. and Vogelstein, B. ( 1990) A genetic model for colorectal tumorigenesis. Cell 61: 759-767.

19.

Fuccio, L. , Zagari, R.M. , Eusebi, L.H. , Laterza, L. , Cennamo, V. , Ceroni, L. et al. (2009) Meta-analysis: can Helicobacter pylori eradication treatment reduce the risk for gastric cancer? Ann Intern Med 151: 121-128.

20.

Funkhouser, E.M. and Sharp, G.B. ( 1995) Aspirin and reduced risk of esophageal carcinoma. Cancer 76: 1116-1119.

21.

Giovannucci, E. , Egan, K.M. , Hunter, D.J. , Stampfer, M.J. , Colditz, G.A. , Willett, W.C. et al. (1995) Aspirin and the risk of colorectal cancer in women. N Engl J Med 333: 609-614.

22.

Giovannucci, E. , Rimm, E.B. , Stampfer, M.J. , Colditz, G.A. , Ascherio, A. and Willett, W.C. ( 1994) Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann Intern Med 121: 241-246.

23.

Gotoda, T. ( 2008) Endoscopic resection for premalignant and malignant lesions of the gastrointestinal tract from the esophagus to the colon. Gastrointest Endosc Clin N Am 18: 435-450.

24.

Gotoda, T. , Yamamoto, H. and Soetikno, R.M. ( 2006) Endoscopic submucosal dissection of early gastric cancer . J Gastroenterol 41: 929-942.

25.

Gotoda, T. , Yanagisawa, A. , Sasako, M. , Ono, H. , Nakanishi, Y. , Shimoda, T. et al. (2000) Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers . Gastric Cancer 3: 219-225.

26.

Half, E. and Arber, N. (2009) Colon cancer: preventive agents and the present status of chemoprevention . Expert Opin Pharmacother 10: 211-219.

27.

Haringsma, J. , Tytgat, G.N. , Yano, H. , Iishi, H. , Tatsuta, M. , Ogihara, T. et al. (2001) Autofluorescence endoscopy: feasibility of detection of GI neoplasms unapparent to white light endoscopy with an evolving technology. Gastrointest Endosc 53: 642-650.

28.

Hillman, L.C. , Chiragakis, L. , Shadbolt, B. , Kaye, G.L. and Clarke, A.C. ( 2004) Proton-pump inhibitor therapy and the development of dysplasia in patients with Barrett’s oesophagus. Med J Aust 180: 387-391.

29.

Hisamichi, S. ( 1989) Screening for gastric cancer. World J Surg 13: 31-37.

30.

Hoff, G. , Grotmol, T. , Skovlund, E. , Bretthauer, M. and Norwegian Colorectal Cancer Prevention Study, G. ( 2009) Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial. Bmj 338: b1846.

31.

Hotta, K. , Oyama, T. , Akamatsu, T. , Tomori, A. , Hasebe, O. , Nakamura, N. et al. (2010) A comparison of outcomes of endoscopic submucosal dissection (ESD) For early gastric neoplasms between high-volume and low-volume centers: multi-center retrospective questionnaire study conducted by the Nagano ESD Study Group. Intern Med 49: 253-259.

32.

Imperiale, T.F. , Ransohoff, D.F. , Itzkowitz, S.H. , Turnbull, B.A. and Ross, M.E. Colorectal Cancer Study Group. (2004) Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med 351: 2704-2714.

33.

Incarbone, R. , Bonavina, L. , Saino, G. , Bona, D. and Peracchia, A. ( 2002) Outcome of esophageal adenocarcinoma detected during endoscopic biopsy surveillance for Barrett’s esophagus. Surg Endosc 16: 263-266.

34.

Jeon, S.W. , Jung, M.K. , Kim, S.K. , Cho, K.B. , Park, K.S. , Park, C.K. et al. (2010) Clinical outcomes for perforations during endoscopic submucosal dissection in patients with gastric lesions. Surg Endosc 24: 911-916.

35.

Jess, T. , Loftus Jr, E.V. , Velayos, F.S. , Winther, K.V. , Tremaine, W.J. , Zinsmeister, A.R. et al. (2007) Risk factors for colorectal neoplasia in inflammatory bowel disease: a nested case-control study from Copenhagen county, Denmark and Olmsted county, Minnesota. Am J Gastroenterol 102: 829-836.

36.

Kerr, D.J. , Dunn, J.A. , Langman, M.J. , Smith, J.L. , Midgley, R.S. , Stanley, A. et al. (2007) Rofecoxib and cardiovascular adverse events in adjuvant treatment of colorectal cancer. N Engl J Med 357: 360-369.

37.

Kudo, S. , Tamura, S. , Nakajima, T. , Yamano, H. , Kusaka, H. and Watanabe, H. ( 1996) Diagnosis of colorectal tumorous lesions by magnifying endoscopy. Gastrointest Endosc 44: 8-14.

38.

Kuipers, E.J. (2010) Barrett’s oesophagus, proton pump inhibitors and gastrin: the fog is clearing. Gut 59: 148-149.

39.

Kuipers, E.J. and Haringsma, J. ( 2005) Diagnostic and therapeutic endoscopy. J Surg Oncol 92: 203-209.

40.

Kune, G.A. , Kune, S. and Watson, L.F. ( 1988) Colorectal cancer risk, chronic illnesses, operations, and medications: case control results from the Melbourne Colorectal Cancer Study. Cancer Res 48: 4399-4404.

41.

Larghi, A. , Lightdale, C.J. , Ross, A.S. , Fedi, P. , Hart, J. , Rotterdam, H. et al. (2007) Long-term follow-up of complete Barrett’s eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma. Endoscopy 39: 1086-1091.

42.

Levin, B. , Lieberman, D.A. , McFarland, B. , Andrews, K.S. , Brooks, D. , Bond, J. et al. (2008) Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 134: 1570-1595.

43.

Loren, D.E. , Lewis, J. and Kochman, M.L. ( 2002) Colon cancer: detection and prevention. Gastroenterol Clin North Am 31: 565-586.

44.

Orlando, R.C. ( 2002) Mechanisms of epithelial injury and inflammation in gastrointestinal diseases. Rev Gastroenterol Disord 2(Suppl 2): S2-8.

45.

Pohl, H. , Sonnenberg, A. , Strobel, S. , Eckardt, A. and Rosch, T. (2009) Endoscopic versus surgical therapy for early cancer in Barrett’s esophagus: a decision analysis. Gastrointest Endosc 70: 623-631.

46.

Poynter, J.N. , Gruber, S.B. , Higgins, P.D. , Almog, R. , Bonner, J.D. , Rennert, H.S. et al. (2005) Statins and the risk of colorectal cancer. N Engl J Med 352: 2184-2192.

47.

Quera, R. , O’Sullivan, K. and Quigley, E.M. ( 2006) Surveillance in Barrett’s oesophagus: will a strategy focused on a high-risk group reduce mortality from oesophageal adenocarcinoma? Endoscopy 38: 162-169.

48.

Ramsoekh, D. , Haringsma, J. and Poley, J.W. ( 2010) A back-to-back comparison of white-light video endoscopy to autofluoroscence endoscopy for adenoma detection in high-ris subjects. Gut 59: [epub ahead of publication].

49.

Raza, A. ( 2000) Consilience across evolving dysplasias affecting myeloid, cervical, esophageal, gastric and liver cells: common themes and emerging patterns. Leuk Res 24: 63-72.

50.

Reid, B.J. , Li, X. , Galipeau, P.C. and Vaughan, T.L. (2010) Barrett’s oesophagus and oesophageal adenocarcinoma: time for a new synthesis. Nat Rev Cancer 10: 87-101.

51.

Rossouw, J.E. , Anderson, G.L. , Prentice, R.L. , LaCroix, A.Z. , Kooperberg, C. , Stefanick, M.L. et al. (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial. Jama 288: 321-333.

52.

Sabharwal, A. and Kerr, D. ( 2007) Chemotherapy for colorectal cancer in the metastatic and adjuvant setting: past, present and future. Expert Rev Anticancer Ther 7: 477-487.

53.

Suzuki, H. , Gotoda, T. , Sasako, M. and Saito, D. ( 2006) Detection of early gastric cancer: misunderstanding the role of mass screening. Gastric Cancer 9: 315-319.

54.

Thun, M.J. , Namboodiri, M.M. and Heath Jr, C.W. ( 1991) Aspirin use and reduced risk of fatal colon cancer. N Engl J Med 325: 1593-1596.

55.

Tsubono, Y. , Nishino, Y. , Tsuji, I. and Hisamichi, S. ( 2000) Screening for gastric cancer in Miyagi, Japan: evaluation with a population-based cancer registry. Asian Pac J Cancer Prev 1: 57-60.

56.

Uedo, N. , Iishi, H. , Tatsuta, M. , Ishihara, R. , Higashino, K. , Takeuchi, Y. et al. (2006) Longterm outcomes after endoscopic mucosal resection for early gastric cancer. Gastric Cancer 9: 88-92.

57.

van Sandick, J.W. , van Lanschot, J.J. , Kuiken, B.W. , Tytgat, G.N. , Offerhaus, G.J. and Obertop, H. ( 1998) Impact of endoscopic biopsy surveillance of Barrett’s oesophagus on pathological stage and clinical outcome of Barrett’s carcinoma . Gut 43: 216-222.

58.

Velayos, F.S. , Loftus Jr, E.V. , Jess, T. , Harmsen, W.S. , Bida, J. , Zinsmeister, A.R. et al. (2006) Predictive and protective factors associated with colorectal cancer in ulcerative colitis: A case-control study. Gastroenterology 130: 1941-1949.

59.

Verdecchia, A. , Mariotto, A. , Gatta, G. , Bustamante-Teixeira, M.T. and Ajiki, W. ( 2003) Comparison of stomach cancer incidence and survival in four continents. Eur J Cancer 39: 1603-1609.

60.

Vieth, M. and Rosch, T. ( 2006) Endoscopic mucosal resection and the risk of lymph-node metastases: indications revisited? Endoscopy 38: 175-179.

61.

Wani, S. and Sharma, P. ( 2007) Endoscopic surface imaging of Barrett’s Esophagus: an optimistic view. Gastroenterology 133: 11-13.

62.

Westerterp, M. , Koppert, L.B. , Buskens, C.J. , Tilanus, H.W. , ten Kate, F.J. , Bergman, J.J. et al. (2005) Outcome of surgical treatment for early adenocarcinoma of the esophagus or gastro-esophageal junction. Virchows Arch 446: 497-504.

63.

Wolfsen, H.C. , Crook, J.E. , Krishna, M. , Achem, S.R. , Devault, K.R. , Bouras, E.P. et al. (2008) Prospective, controlled tandem endoscopy study of narrow band imaging for dysplasia detection in Barrett’s Esophagus . Gastroenterology 135: 24-31.